-- Kure Care, a division of Veracor Group LLC, urges Medicare beneficiaries with chronic wounds to seek treatment before January 1, 2026, when stricter coverage requirements take effect.
The upcoming changes were detailed in a press release published on October 31st by CMS.gov.
CEO Kenton Gray advises patients to understand their coverage options under current policies, which will soon require mandatory four-week standard care periods before qualifying for advanced treatments. The policy shift also imposes limitations on the number of covered applications per treatment episode, creating a narrow window for beneficiaries seeking alternatives to traditional wound care methods that have failed to deliver results.
More information is available at https://curewounds.com
Chronic wounds—including diabetic foot ulcers, venous leg ulcers, and pressure injuries—affect millions of Americans, yet traditional treatment approaches often fail to produce timely healing. Margaret Thompson of Phoenix, Arizona, experienced this firsthand when her diabetic foot ulcer persisted for eight months under conventional care without improvement. Her case illustrates why patients and clinicians alike are considering regenerative medicine as a viable alternative that addresses the limitations of standard wound management protocols.
According to Kure Care's clinical outcomes, the company connects patients to biologics-based regenerative treatments that heal wounds 90 percent faster than traditional methods. The platform integrates certified specialists with advanced therapies designed to accelerate tissue repair and reduce recovery time for individuals whose wounds have resisted conventional approaches, directly addressing the prolonged suffering and diminished quality of life that accompany slow-healing injuries.
Financial barriers often prevent patients from accessing advanced medical interventions. Kure Care reports that 95 percent of qualified patients receive full Medicare coverage for their treatments, which removes a significant obstacle for beneficiaries who might otherwise forgo regenerative options due to cost concerns. The company's focus on Medicare-eligible populations ensures that older adults and individuals with disabilities can access biologics-based care without prohibitive out-of-pocket expenses now under the current Medicare rules.
A nationwide network of more than 500 certified wound care specialists enables patients across the country to receive advanced treatment close to home through Kure Care. Geographic disparities in access to specialized care, particularly for beneficiaries in rural or underserved areas, are addressed through this infrastructure. Regenerative therapies are not confined to major metropolitan centers but are available in communities where chronic wounds pose significant health challenges.
The patient pathway begins with an eligibility assessment through a brief online quiz, followed by connection to a local certified provider who develops a personalized treatment plan. Patients then start their regenerative therapy regimen while tracking healing progress through real-time monitoring tools. Administrative friction is reduced through this streamlined process, allowing beneficiaries to move quickly from initial inquiry to active treatment, which is particularly important given the upcoming policy changes.
Patient outcomes validate the efficacy of the regenerative approach. After Thompson's eight months of unsuccessful traditional treatment, her wound healed in six weeks following regenerative therapy, with Medicare covering the full cost. Robert Martinez of Tampa, Florida, reported rapid and painless healing of his venous leg ulcer. Linda Chen of Sacramento, California, achieved complete healing of a pressure wound and regained mobility. These cases demonstrate measurable improvements in both healing time and functional recovery.
With new Medicare policies set to impose stricter clinical requirements in less than two months, beneficiaries face a closing window under current coverage rules. Gray's advisory emphasizes the importance of acting now to verify eligibility and initiate treatment before January 2026. Patients who delay risk encountering additional procedural hurdles that could postpone access to advanced therapies.
Kure Care, as a division of Veracor Group LLC, has facilitated healing for more than 10,000 patients through its integrated platform. The company continues to expand access to regenerative wound care for Medicare beneficiaries nationwide. For eligibility verification and provider connection, visit https://curewounds.com
Contact Info:
Name: Kenton Gray
Email: Send Email
Organization: Kure Care a division of Veracor Group LLC
Address: 1150 NW 72ND AVE TOWER 1 STE 455 #20073 , Miami, FL 33126, United States
Website: https://curewounds.com
Release ID: 89174799